Safety study of GR2303 in healthy adults
This trial tests a new drug called GR2303 to see if it is safe and how the body processes it. It is for healthy adults who have not used similar drugs before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult.
- You must sign a consent form agreeing to join the study.
- You cannot have any serious ongoing medical condition.
- You cannot have used a drug that targets TNF-like cytokine 1A before.
- You cannot have a history of cancer.
- You must test negative for hepatitis B, hepatitis C, and HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called GR2301 in healthy volunteers to see if it is safe. It is a phase 1 study, which means it is the first time this drug is being given to people.
This trial is testing an investigational medication called GR2301 in healthy adults. It aims to see how the drug behaves in the body and if it is safe, which is a first step before studying it in people with medical conditions.
This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
This trial tests whether a new medicine (AG2304) is safe in healthy adults compared to taking two other medicines (AG23041 and AG23042) together. It aims to find out how the body handles the new medicine.
This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.
Hear when a new Health Adult Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.